We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · July 27, 2022

Effect of Sodium Phenylbutyrate/Taurursodiol on Tracheostomy/Ventilation-Free Survival and Hospitalisation in ALS

Journal of Neurology, Neurosurgery, and Psychiatry


Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Neurology, Neurosurgery, and Psychiatry
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial
J. Neurol. Neurosurg. Psychiatr. 2022 May 16;[EPub Ahead of Print], S Paganoni, S Hendrix, SP Dickson, N Knowlton, JD Berry, MA Elliott, S Maiser, C Karam, JB Caress, MA Owegi, A Quick, J Wymer, SA Goutman, D Heitzman, TD Heiman-Patterson, C Jackson, C Quinn, JD Rothstein, EJ Kasarskis, J Katz, L Jenkins, SS Ladha, TM Miller, SN Scelsa, TH Vu, C Fournier, KM Johnson, A Swenson, N Goyal, GL Pattee, S Babu, M Chase, D Dagostino, M Hall, G Kittle, M Eydinov, J Ostrow, L Pothier, R Randall, JM Shefner, AV Sherman, E Tustison, P Vigneswaran, H Yu, J Cohen, J Klee, R Tanzi, W Gilbert, P Yeramian, M Cudkowicz

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading